Literature DB >> 33384

Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.

U Klein, H Kresse, K von Figura.   

Abstract

Removal of N-sulfated glucosamine residues during degradation of heparan sulfate is accomplished by the sequential action of three enzymes. Action of sulfamidase results in the formation of alpha-glucosaminide residues. Removal of these groups requires conversion to alpha-N-acetylglucosaminide by the action of an acetyltransferase in the presence of acetyl-CoA, followed by hydrolysis by alpha-N-acetylglucosaminidase. In fibroblast homogenates from three patients with Sanfilippo syndrome type C (mucopolysaccharidosis III C), a biochemical variant of the Sanfilippo syndrome, complete deficiency of the acetyl-CoA:alpha-glucosaminide N-acetyltransferase activity was detected. Activities of all lysosomal hydrolases known so far to degrade mucopolysaccharides, including those of sulfamidase and alpha-N-acetylglucosaminidase, were in the range of controls. Acetyl-CoA:alpha-glucosaminide N-acetyltransferase activity was normal in fibroblasts of patients with other genetic mucopolysaccharidoses, including Sanfilippo syndrome A and B.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 33384      PMCID: PMC336290          DOI: 10.1073/pnas.75.10.5185

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  A heparan sulfate-degrading endoglycosidase from rat liver tissue.

Authors:  M Höök; A Wasteson; A Oldberg
Journal:  Biochem Biophys Res Commun       Date:  1975-12-15       Impact factor: 3.575

2.  Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.

Authors:  U Klein; H Kresse; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

3.  Partial purification and characterization of heparan sulfate specific endoglucuronidase.

Authors:  U Klein; K Von Figura
Journal:  Biochem Biophys Res Commun       Date:  1976-12-06       Impact factor: 3.575

4.  Structure and biosynthesis of heparin-like polysaccharides.

Authors:  U Lindahl; M Höök; G Bäckström; I Jacobsson; J Riesenfeld; A Malmström; L Rodén; D S Feingold
Journal:  Fed Proc       Date:  1977-01

5.  Demonstration of a platelet enzyme, degrading heparan sulphate.

Authors:  A Wasteson; M Höök; B Westermark
Journal:  FEBS Lett       Date:  1976-04-15       Impact factor: 4.124

6.  Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans in normals and four types of mucopolysaccharidoses.

Authors:  G Constantopoulos; R D McComb; A S Dekaban
Journal:  J Neurochem       Date:  1976-05       Impact factor: 5.372

Review 7.  Inherited disorders of lysosomal metabolism.

Authors:  E F Neufeld; T W Lim; L J Shapiro
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

8.  A sensitive procedure for the diagnosis of N-acetyl-galactosamine-6-sulfate sulfatase deficiency in classical Morquio's disease.

Authors:  J Glössl; H Kresse
Journal:  Clin Chim Acta       Date:  1978-08-15       Impact factor: 3.786

9.  Human alpha-N-acetylglucosaminidase. 1. Purification and properties.

Authors:  K von Figura
Journal:  Eur J Biochem       Date:  1977-11-01

10.  Characterization of glycosaminoglycans stored in mucopolysaccharidosis III A: evidence for a generally occuring degradation of heparan sulfate by endoglycosidases.

Authors:  A Kindler; U Klein; K von Figura
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-11
View more
  28 in total

1.  Structure of heparan sulphate oligosaccharides and their degradation by exo-enzymes.

Authors:  A Linker
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

2.  Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.

Authors:  Carla Martins; Helena Hůlková; Larbi Dridi; Virginie Dormoy-Raclet; Lubov Grigoryeva; Yoo Choi; Alexander Langford-Smith; Fiona L Wilkinson; Kazuhiro Ohmi; Graziella DiCristo; Edith Hamel; Jerôme Ausseil; David Cheillan; Alain Moreau; Eva Svobodová; Zuzana Hájková; Markéta Tesařová; Hana Hansíková; Brian W Bigger; Martin Hrebícek; Alexey V Pshezhetsky
Journal:  Brain       Date:  2015-01-06       Impact factor: 13.501

3.  Sanfilippo type D disease: clinical findings in two patients with a new variant of mucopolysaccharidosis III.

Authors:  R Gatti; C Borrone; P Durand; S De Virgilis; G Sanna; A Cao; K von Figura; H Kresse; E Paschke
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

4.  The mucopolysaccharidoses: biochemistry and clinical symptoms.

Authors:  H Kresse; M Cantz; K von Figura; J Glössl; E Paschke
Journal:  Klin Wochenschr       Date:  1981-08-17

5.  Effect of acidotropic amines on the accumulation of newly synthesized membrane and luminal proteins in Chinese-hamster ovary (CHO) cell lysosomes.

Authors:  E A Madden; B Storrie
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

6.  A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise.

Authors:  Yewande Pearse; Michelina Iacovino
Journal:  Med Res Arch       Date:  2020-02-21

7.  Human acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase. Kinetic characterization and mechanistic interpretation.

Authors:  P J Meikle; A M Whittle; J J Hopwood
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Novel Direct Assay for Acetyl-CoA:α-Glucosaminide N-Acetyltransferase Using BODIPY-Glucosamine as a Substrate.

Authors:  Yoo Choi; Alexander B Tuzikov; Tatyana V Ovchinnikova; Nicolai V Bovin; Alexey V Pshezhetsky
Journal:  JIMD Rep       Date:  2015-10-23

9.  Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.

Authors:  G V Coppa; P L Giorgi; L Felici; O Gabrielli; E Donti; S Bernasconi; H Kresse; E Paschke; C Mastropaolo
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

10.  Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C.

Authors:  Matthew Feldhammer; Stéphanie Durand; Alexey V Pshezhetsky
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.